ROGER J. POMERANTZ, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Viracta Therapeutics, Inc.

Filing Date Source Excerpt
2022-04-27 The following table sets forth the names, ages as of April 19, 2022, and certain other information for each of our directors and director nominees: Roger J. Pomerantz, M.D., Chairman of the Board, Age 65, Director since 2021. Director Compensation table shows total compensation of $1,731,797.
2023-04-27 Dr. Pomerantz has served as a member of the board of directors since February 2021. ... Chairman of the Board. Director Compensation: Roger J. Pomerantz, M.D. - Total ($) 322,786.
2024-04-26 Dr. Pomerantz has served as a member of the board of directors since February 2021. ... Dr. Pomerantz received his B.A. in Biochemistry at the Johns Hopkins University and his M.D. at the Johns Hopkins School of Medicine. ... The following table sets forth information regarding the total compensation awarded to, earned by or paid to our non-employee directors for their service on our board of directors, for the fiscal year ended December 31, 2023. ... Roger J. Pomerantz, M.D. Fees Paid or Earned in Cash ($) 150,000 Option Awards($) 60,267 Total ($) 210,267 ... Pursuant to the Outside Director Compensation Policy, in August 2023 Dr. Pomerantz received an option to purchase an additional 15,000 shares of our common stock in recognition of his services as Chairperson of the board of directors.

Data sourced from SEC filings. Last updated: 2026-03-09